Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. A calculation from the Medical Council shows that out ...
Sarepta Therapeutics (Nasdaq: SRPT) has announced it will cease development of SRP-5051, an experimental drug for Duchenne ...
The US Food and Drug Administration (FDA) plays a pivotal role in fostering the development of treatments for rare diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback